Past Data
Ticker | Date | Current phase | Disease Area | Market cap | BIOTECH CALCULATOR % PROBABILITY | Trial outcome |
---|---|---|---|---|---|---|
ITEK | 08/19/2017 | 3 | Opthalmology | $240M | 40.9 | fail |
AGRX | 08/19/2017 | 3 | other | $143.73m | 47.5 | fail |
OTIC | 08/19/2017 | 3 | Infectious disease | $489.15M | 51.85 | success |
TENX | 08/19/2017 | 3 | Other | $65.24M | 47.5 | fail |
ANTH | 08/19/2017 | 3 | Autoimmune | $89.3m | 34.1 | Fail |
OPHT | 08/19/2017 | 3 | Ophthalmology | $1.3B | 52.6 | fail |
NOVN | 08/19/2017 | 3 | Skin infections | $305m | 51.75 | fail 1/27 |
CATB | 08/19/2017 | 2 | other | $75.1M | 31.9 | fail |
TRVN | 08/19/2017 | 3 | other | $372M | 50.75 | success |
AVIR | 08/19/2017 | 2 | infections disease | $48.69M | 33.55 | fail |
AXON | 08/19/2017 | 2 | Dementia | $1.22B | 11.7 | |
NDRM | 08/19/2017 | 2 | Neurology | $600.73m | 29.4 | Success |
CELG | 08/19/2017 | 3 | Multiples Scerosis (Other) | 94B | 59.2 | Success |
CDTX | 08/19/2017 | 2 | Infection | $195.08M | 33.55 | fail |
CYCC | 08/19/2017 | 3 | Other | $22M | 47.5 | fail |
BCRX | 08/19/2017 | 2 | -- | $406.21M | ||
LJPC | 08/19/2017 | 3 | Cardiovascular | 332.59M | 41.95 | Success* |
ACOR | 08/19/2017 | 3 | Neurology/Parkinson's dz | $943M | 52.05 | Success |
PTCT | 08/19/2017 | 3 | Other | $448.54M | 50.2 | fail |
AUPH | 08/19/2017 | 2 | Autoimmune | $196.65m | 27.5 | Success |
KPTI | 08/19/2017 | 2 | Other | $570.81M | 31.9 | fail |
TGTX | 08/19/2017 | 3 | Other | $292.81M | 47.5 | Success* |
IONS | 08/19/2017 | 3 | Other | $6.10B | 59.2 | Success |
NKTR | 08/19/2017 | 3 | Other (Opiod) | $2.37B | 59.2 | Success |
CRBP | 08/19/2017 | 2 | Cystic Fibrosis (Other) | $462.67M | 34.6 | |
GNMX | 2 | Other | $219.99M | 31.9 | fail | |
LLY | 3 | Other (Breast Cancer) | $88.38B | 59.2 | Success | |
RARE | 2 | Other (Seizure) | $3.27b | 43.6 | FAIL | |
XENE | 2 | Other (facial acne) | 176.67M | 31.9 | fail | |
FOMX | 3 | All indications | $338.23M | 44.5 | FAIL | |
VRTX | 3 | Other (Cystic Fibrosis) | $22.28B | 55.7 | Success | |
PRTK | 3 | Infections disease | $495.86M | 51.85 | Success | |
NVCR | 3 | Oncology | $713.52M | 33.7 | Success | |
OMED | 2 | Oncology | $327.61M | 26.35 | Fail | |
RARE | 3 | Other | $2.50B | 59.2 | Success | |
NTRP | 2 | Alzheimer's | $147.43M | 9.9 | Fail | |
AEZS | 3 | Other | $49.93M | 48.4 | Fail | |
ITEK | 2 | Opthalmology | 46.55M | 33.75 | Fail | |
ZYNE | 2 | Others | $200M | 31.9 |